These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16556617)

  • 1. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
    Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
    Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
    Kim M; Kim JH; Kim JH; Kim DH; Yu YS
    Korean J Ophthalmol; 2010 Feb; 24(1):35-9. PubMed ID: 20157412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.
    Balla MM; Vemuganti GK; Kannabiran C; Honavar SG; Murthy R
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1506-14. PubMed ID: 19029022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
    Youssef NS; Said AM
    Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell characteristics in retinoblastoma.
    Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
    Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas ligand in retinoblastoma.
    Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
    Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
    Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress of cancer stem cells of solid tumor].
    Ni XG; Zhao P
    Ai Zheng; 2006 Jun; 25(6):775-8. PubMed ID: 16764780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
    Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
    Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells.
    Huang L; Lu Q; Han Y; Li Z; Zhang Z; Li X
    Diagn Pathol; 2012 Dec; 7():180. PubMed ID: 23244569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.